TrialJournal of surgical oncology2025

Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer.

Nataliya V Uboha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.